Bausch Health Appoints New Chief Accounting Officer
Bausch Health (NYSE:BHC) has appointed Steven Lee as Senior Vice President, Controller and Chief Accounting Officer, effective July 14, 2025. Lee brings over two decades of experience in financial transformation, mergers and acquisitions, and operational execution.
Prior to joining Bausch Health, Lee served as Vice President and CFO of the Industrial and Energy Division and North America Division at BrandSafway, where he also held the position of Chief Accounting Officer. His previous experience includes leadership roles at Mohawk Industries as VP, Corporate Controller, and Chief Accounting Officer.
Bausch Health (NYSE:BHC) ha nominato Steven Lee come Senior Vice President, Controller e Chief Accounting Officer, a partire dal 14 luglio 2025. Lee vanta oltre vent'anni di esperienza nella trasformazione finanziaria, fusioni e acquisizioni e nell'esecuzione operativa.
Prima di entrare in Bausch Health, Lee è stato Vice President e CFO della Divisione Industriale ed Energetica e della Divisione Nord America presso BrandSafway, dove ha ricoperto anche il ruolo di Chief Accounting Officer. In precedenza, ha ricoperto posizioni di leadership presso Mohawk Industries come VP, Corporate Controller e Chief Accounting Officer.
Bausch Health (NYSE:BHC) ha nombrado a Steven Lee como Senior Vice President, Controller y Chief Accounting Officer, con efecto a partir del 14 de julio de 2025. Lee aporta más de dos décadas de experiencia en transformación financiera, fusiones y adquisiciones, y ejecución operativa.
Antes de unirse a Bausch Health, Lee fue Vicepresidente y CFO de la División Industrial y Energética y de la División de Norteamérica en BrandSafway, donde también ocupó el cargo de Chief Accounting Officer. Su experiencia anterior incluye roles de liderazgo en Mohawk Industries como VP, Corporate Controller y Chief Accounting Officer.
Bausch Health (NYSE:BHC)는 2025년 7월 14일부로 Steven Lee를 수석 부사장, 컨트롤러 및 최고 회계 책임자로 임명했습니다. Lee는 금융 혁신, 인수합병 및 운영 실행 분야에서 20년 이상의 경험을 보유하고 있습니다.
Bausch Health에 합류하기 전, Lee는 BrandSafway에서 산업 및 에너지 부문과 북미 부문의 부사장 겸 CFO를 역임했으며, 최고 회계 책임자 직책도 수행했습니다. 이전에는 Mohawk Industries에서 부사장, 기업 컨트롤러 및 최고 회계 책임자 등 리더십 역할을 맡았습니다.
Bausch Health (NYSE:BHC) a nommé Steven Lee au poste de Senior Vice President, Controller et Chief Accounting Officer, à compter du 14 juillet 2025. Lee apporte plus de vingt ans d'expérience en transformation financière, fusions et acquisitions, ainsi qu'en exécution opérationnelle.
Avant de rejoindre Bausch Health, Lee a occupé les fonctions de Vice-président et CFO de la division Industrielle et Énergétique ainsi que de la division Amérique du Nord chez BrandSafway, où il a également été Chief Accounting Officer. Son expérience antérieure inclut des postes de direction chez Mohawk Industries en tant que VP, Corporate Controller et Chief Accounting Officer.
Bausch Health (NYSE:BHC) hat Steven Lee zum Senior Vice President, Controller und Chief Accounting Officer mit Wirkung zum 14. Juli 2025 ernannt. Lee bringt über zwanzig Jahre Erfahrung in den Bereichen finanzielle Transformation, Fusionen und Übernahmen sowie operative Umsetzung mit.
Vor seinem Eintritt bei Bausch Health war Lee Vice President und CFO der Industrie- und Energiesparte sowie der Nordamerika-Sparte bei BrandSafway, wo er auch die Position des Chief Accounting Officer innehatte. Zuvor hatte er Führungspositionen bei Mohawk Industries als VP, Corporate Controller und Chief Accounting Officer inne.
- Appointment of experienced executive with over 20 years in financial leadership
- New CAO brings significant M&A and financial transformation expertise
- Addition strengthens finance leadership team during company transformation period
- Transition period may require adjustment time for new accounting leadership
LAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Steven Lee as Senior Vice President, Controller and Chief Accounting Officer, effective Monday, July 14.
Steven brings extensive experience in financial transformation, mergers and acquisitions, and operational execution. With over two decades of experience, Steven has consistently demonstrated his proficiency in capital strategy to drive long-term value. Before joining Bausch Health, he served as Vice President and Chief Financial Officer of the Industrial and Energy Division and the North America Division, for BrandSafway, a portfolio company of Clayton, Dubilier & Rice and Brookfield Business Partners. He also served as Vice President and Chief Accounting Officer at BrandSafway. Previously, at Mohawk Industries, he held the roles of Vice President, Corporate Controller, and Chief Accounting Officer, along with other senior financial and operational management positions.
"We are excited to add Steven to our finance leadership team as our new Controller and Chief Accounting Officer," said JJ Charhon, Chief Financial Officer, Bausch Health. "His depth and breadth of experience will be a great addition to the finance function as we continue to support Bausch Health's transformation journey toward continued innovation and profitable growth."
In his new role, Steven will oversee the company's financial reporting and corporate controllership.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
Investor Contact:
Garen Sarafian
ir@bauschhealth.com
(877) 281-6642 (toll free)
Media Contact:
Katie Savastano
corporate.communications@bauschhealth.com
(908) 569-3692
SOURCE: Bausch Health Companies Inc
View the original press release on ACCESS Newswire
FAQ
Who is the new Chief Accounting Officer of Bausch Health (BHC)?
What is Steven Lee's previous experience before joining Bausch Health?
When does Steven Lee start his role at Bausch Health (BHC)?
What will be Steven Lee's responsibilities at Bausch Health?
Why did Bausch Health appoint a new Chief Accounting Officer?
